Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trial NCT00867932 · COMPLETED
Trial details
- NCT number
- NCT00867932
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-02
- Primary completion
- 2011-05-12
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.